| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 6.42e-07 | 14 | 103 | 4 | GO:0032454 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 6.42e-07 | 14 | 103 | 4 | GO:0070679 | |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 2.64e-06 | 6 | 103 | 3 | GO:0140684 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.17e-05 | 98 | 103 | 6 | GO:0051213 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.24e-05 | 28 | 103 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.89e-05 | 31 | 103 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide binding | 2.13e-05 | 11 | 103 | 3 | GO:0019103 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.14e-05 | 65 | 103 | 5 | GO:0016706 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.15e-05 | 32 | 103 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | CTP binding | 2.64e-05 | 2 | 103 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 4.78e-05 | 39 | 103 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 5.29e-05 | 40 | 103 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | demethylase activity | 7.73e-05 | 44 | 103 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 7.88e-05 | 3 | 103 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.18e-04 | 49 | 103 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | UTP binding | 1.57e-04 | 4 | 103 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.86e-04 | 102 | 103 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 2.53e-04 | 109 | 103 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | procollagen-proline 4-dioxygenase activity | 2.61e-04 | 5 | 103 | 2 | GO:0004656 | |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 2.61e-04 | 5 | 103 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 2.61e-04 | 5 | 103 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 3.90e-04 | 6 | 103 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA4 ABCA13 ABCB5 UPF1 ABCG1 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 4.63e-04 | 441 | 103 | 9 | GO:0016887 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.71e-04 | 70 | 103 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 5.44e-04 | 7 | 103 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 5.53e-04 | 73 | 103 | 4 | GO:0044183 | |
| GeneOntologyMolecularFunction | TPR domain binding | 7.23e-04 | 8 | 103 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | peptidyl-proline 4-dioxygenase activity | 7.23e-04 | 8 | 103 | 2 | GO:0031545 | |
| GeneOntologyMolecularFunction | procollagen-proline dioxygenase activity | 7.23e-04 | 8 | 103 | 2 | GO:0019798 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 9.26e-04 | 9 | 103 | 2 | GO:0032552 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 1.15e-03 | 10 | 103 | 2 | GO:0030235 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V0C ABCA4 ABCA13 ABCB5 UPF1 ABCG1 HSP90AA1 HSP90AA4P HSP90AA2P HSP90AB1 | 1.27e-03 | 614 | 103 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.41e-03 | 11 | 103 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.68e-03 | 12 | 103 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | peptidyl-proline dioxygenase activity | 1.68e-03 | 12 | 103 | 2 | GO:0031543 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.72e-03 | 46 | 103 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.30e-03 | 178 | 103 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.32e-03 | 51 | 103 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | transporter activity | ATP6V0C ABCA4 ABCA13 ABCB5 TRPC4 TRPC5 AQP3 SLC45A4 ITPR3 CLPTM1L ABCG1 SLC18A1 SLC16A14 NIPAL2 TRPM8 | 2.48e-03 | 1289 | 103 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP6V0C ABCA4 ABCA13 ABCB5 TRPC4 TRPC5 AQP3 SLC45A4 ITPR3 ABCG1 SLC18A1 SLC16A14 NIPAL2 TRPM8 | 2.93e-03 | 1180 | 103 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.02e-03 | 16 | 103 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.28e-03 | 477 | 103 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.34e-03 | 194 | 103 | 5 | GO:0016705 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 4.13e-03 | 126 | 103 | 4 | GO:0051082 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.49e-03 | 129 | 103 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | L-ascorbic acid binding | 4.71e-03 | 20 | 103 | 2 | GO:0031418 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.19e-03 | 21 | 103 | 2 | GO:0030228 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 6.91e-05 | 3 | 101 | 2 | GO:0030934 | |
| GeneOntologyCellularComponent | procollagen-proline 4-dioxygenase complex | 6.91e-05 | 3 | 101 | 2 | GO:0016222 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.63e-04 | 320 | 101 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.22e-04 | 354 | 101 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | stereocilium membrane | 3.42e-04 | 6 | 101 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 4.90e-04 | 32 | 101 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | basal part of cell | 4.97e-04 | 378 | 101 | 8 | GO:0045178 | |
| Domain | JmjC | 7.88e-06 | 24 | 101 | 4 | PF02373 | |
| Domain | JmjN | 1.79e-05 | 10 | 101 | 3 | SM00545 | |
| Domain | JmjN | 1.79e-05 | 10 | 101 | 3 | PF02375 | |
| Domain | JMJN | 1.79e-05 | 10 | 101 | 3 | PS51183 | |
| Domain | JmjN | 1.79e-05 | 10 | 101 | 3 | IPR003349 | |
| Domain | JMJC | 2.58e-05 | 32 | 101 | 4 | PS51184 | |
| Domain | JmjC_dom | 2.58e-05 | 32 | 101 | 4 | IPR003347 | |
| Domain | DUF3697_Uba2 | 2.90e-05 | 2 | 101 | 2 | IPR022166 | |
| Domain | DUF5050 | 2.90e-05 | 2 | 101 | 2 | IPR032485 | |
| Domain | DUF3697 | 2.90e-05 | 2 | 101 | 2 | PF12478 | |
| Domain | DUF5050 | 2.90e-05 | 2 | 101 | 2 | PF16472 | |
| Domain | JmjC | 2.92e-05 | 33 | 101 | 4 | SM00558 | |
| Domain | P4Ha_N | 8.66e-05 | 3 | 101 | 2 | PF08336 | |
| Domain | Heat_shock_protein_90_CS | 8.66e-05 | 3 | 101 | 2 | IPR019805 | |
| Domain | Pro_4_hyd_alph_N | 8.66e-05 | 3 | 101 | 2 | IPR013547 | |
| Domain | ABC_tran | 1.31e-04 | 48 | 101 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.31e-04 | 48 | 101 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.42e-04 | 49 | 101 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 1.53e-04 | 50 | 101 | 4 | IPR003439 | |
| Domain | Hsp90_fam | 1.73e-04 | 4 | 101 | 2 | IPR001404 | |
| Domain | Hsp90_N | 1.73e-04 | 4 | 101 | 2 | IPR020575 | |
| Domain | HSP90 | 1.73e-04 | 4 | 101 | 2 | PF00183 | |
| Domain | HSP90 | 1.73e-04 | 4 | 101 | 2 | PS00298 | |
| Domain | TRP_2 | 4.28e-04 | 6 | 101 | 2 | PF08344 | |
| Domain | TRP_dom | 4.28e-04 | 6 | 101 | 2 | IPR013555 | |
| Domain | TRPC_channel | 5.97e-04 | 7 | 101 | 2 | IPR002153 | |
| Domain | - | 1.22e-03 | 39 | 101 | 3 | 2.120.10.30 | |
| Domain | ABC_transporter_CS | 1.51e-03 | 42 | 101 | 3 | IPR017871 | |
| Domain | TRP_channel | 1.54e-03 | 11 | 101 | 2 | IPR004729 | |
| Domain | 2OG-FeII_Oxy_3 | 1.54e-03 | 11 | 101 | 2 | PF13640 | |
| Domain | ABC_A | 1.84e-03 | 12 | 101 | 2 | IPR026082 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.97e-03 | 46 | 101 | 3 | IPR011042 | |
| Domain | - | 1.97e-03 | 46 | 101 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 2.23e-03 | 48 | 101 | 3 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 2.36e-03 | 49 | 101 | 3 | IPR002172 | |
| Domain | LDLa | 2.36e-03 | 49 | 101 | 3 | SM00192 | |
| Domain | LDLRA_2 | 2.36e-03 | 49 | 101 | 3 | PS50068 | |
| Domain | Ldl_recept_b | 2.53e-03 | 14 | 101 | 2 | PF00058 | |
| Domain | LDLRB | 2.53e-03 | 14 | 101 | 2 | PS51120 | |
| Domain | LY | 2.90e-03 | 15 | 101 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.90e-03 | 15 | 101 | 2 | IPR000033 | |
| Domain | P4Hc | 3.31e-03 | 16 | 101 | 2 | SM00702 | |
| Domain | SEC7 | 3.31e-03 | 16 | 101 | 2 | PS50190 | |
| Domain | Sec7 | 3.31e-03 | 16 | 101 | 2 | SM00222 | |
| Domain | Sec7_dom | 3.31e-03 | 16 | 101 | 2 | IPR000904 | |
| Domain | Pro_4_hyd_alph | 3.31e-03 | 16 | 101 | 2 | IPR006620 | |
| Domain | Ion_trans_dom | 3.41e-03 | 114 | 101 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.41e-03 | 114 | 101 | 4 | PF00520 | |
| Domain | HATPase_c | 4.19e-03 | 18 | 101 | 2 | SM00387 | |
| Domain | HATPase_c | 4.66e-03 | 19 | 101 | 2 | PF02518 | |
| Domain | 2OG-FeII_Oxy | 4.66e-03 | 19 | 101 | 2 | PF03171 | |
| Domain | - | 5.16e-03 | 20 | 101 | 2 | 3.30.565.10 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.79e-05 | 90 | 86 | 6 | M631 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.42e-05 | 61 | 86 | 5 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.39e-05 | 67 | 86 | 5 | M26999 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 7.60e-05 | 14 | 86 | 3 | MM15029 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 9.88e-05 | 76 | 86 | 5 | MM14573 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.16e-04 | 16 | 86 | 3 | M16498 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.46e-04 | 44 | 86 | 4 | M11911 | |
| Pubmed | Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis. | 2.60e-08 | 3 | 104 | 3 | 29386344 | |
| Pubmed | Mapping of the gene family for human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. | 1.04e-07 | 4 | 104 | 3 | 1740332 | |
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 23589305 | ||
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 1.34e-07 | 16 | 104 | 4 | 16269234 | |
| Pubmed | 2.59e-07 | 5 | 104 | 3 | 21914792 | ||
| Pubmed | Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. | 2.59e-07 | 5 | 104 | 3 | 16738407 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIVEP2 MINK1 ST3GAL3 ADGRV1 STK32C JMJD1C TATDN3 ARFGEF3 MALT1 ABCG1 PPP4C UBAP2L SLC16A14 LRP1 PAK3 STYXL1 XYLB KDM4B | 4.23e-07 | 1489 | 104 | 18 | 28611215 |
| Pubmed | Identification and characterization of JMJD2 family genes in silico. | 5.16e-07 | 6 | 104 | 3 | 15138608 | |
| Pubmed | P4HA2 ATP6V0C RANBP2 LAMA4 ITGA6 CUL9 UPF1 ATP5MK P4HA1 LRP1 ALDH2 HSP90AA1 HSP90AB1 | 1.80e-06 | 859 | 104 | 13 | 31536960 | |
| Pubmed | 2.15e-06 | 9 | 104 | 3 | 11290752 | ||
| Pubmed | 4.21e-06 | 11 | 104 | 3 | 19144645 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.37e-06 | 332 | 104 | 8 | 32786267 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 8.86e-06 | 2 | 104 | 2 | 15963947 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 38081527 | ||
| Pubmed | Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif. | 8.86e-06 | 2 | 104 | 2 | 22848402 | |
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 8.86e-06 | 2 | 104 | 2 | 3458168 | |
| Pubmed | Mechanism of dimer formation of the 90-kDa heat-shock protein. | 8.86e-06 | 2 | 104 | 2 | 7588731 | |
| Pubmed | Reader domain specificity and lysine demethylase-4 family function. | 8.86e-06 | 2 | 104 | 2 | 27841353 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 34218269 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33080545 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31885746 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37011862 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26651243 | ||
| Pubmed | RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia. | 8.86e-06 | 2 | 104 | 2 | 24613277 | |
| Pubmed | Endothelial podosome rosettes regulate vascular branching in tumour angiogenesis. | 8.86e-06 | 2 | 104 | 2 | 25218639 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37406487 | ||
| Pubmed | Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors. | 8.86e-06 | 2 | 104 | 2 | 22194440 | |
| Pubmed | Circadian expression of 86- and 84-kDa heat shock proteins in the mouse suprachiasmatic nucleus. | 8.86e-06 | 2 | 104 | 2 | 18480550 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9211872 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22457348 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 23677990 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22841823 | ||
| Pubmed | Involvement of TRPC4 and 5 Channels in Persistent Firing in Hippocampal CA1 Pyramidal Cells. | 8.86e-06 | 2 | 104 | 2 | 32033274 | |
| Pubmed | Substitution of only two residues of human Hsp90alpha causes impeded dimerization of Hsp90beta. | 8.86e-06 | 2 | 104 | 2 | 18347946 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17624425 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 35633597 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12524348 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19047110 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 19383717 | ||
| Pubmed | Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. | 8.86e-06 | 2 | 104 | 2 | 24470379 | |
| Pubmed | Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line. | 8.86e-06 | 2 | 104 | 2 | 12136260 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10376793 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 34899056 | ||
| Pubmed | Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | 8.86e-06 | 2 | 104 | 2 | 17593972 | |
| Pubmed | Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target. | 8.86e-06 | 2 | 104 | 2 | 33179566 | |
| Pubmed | Regulation of embryonic stem cell pluripotency by heat shock protein 90. | 8.86e-06 | 2 | 104 | 2 | 22696450 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22895790 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25714495 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26317356 | ||
| Pubmed | Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. | 8.86e-06 | 2 | 104 | 2 | 19576239 | |
| Pubmed | Proline hydroxylation in collagen supports integrin binding by two distinct mechanisms. | 8.86e-06 | 2 | 104 | 2 | 29615493 | |
| Pubmed | A novel capacitative calcium entry channel expressed in excitable cells. | 8.86e-06 | 2 | 104 | 2 | 9687496 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2925609 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32338378 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 2469626 | ||
| Pubmed | Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene. | 8.86e-06 | 2 | 104 | 2 | 2591742 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 27630312 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 36270993 | ||
| Pubmed | Hsp90 regulation of fibroblast activation in pulmonary fibrosis. | 8.86e-06 | 2 | 104 | 2 | 28239659 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37028636 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 26755577 | ||
| Pubmed | Conserved conformational changes in the ATPase cycle of human Hsp90. | 8.86e-06 | 2 | 104 | 2 | 18400751 | |
| Pubmed | TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. | 8.86e-06 | 2 | 104 | 2 | 30038709 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 22019372 | ||
| Pubmed | Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. | 9.23e-06 | 14 | 104 | 3 | 16603238 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.37e-05 | 101 | 104 | 5 | 23382219 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL3A1 MTA2 P4HA2 COL7A1 COL12A1 LAMA4 ITGA6 EXT1 LRP1B P3H4 KLHL11 CLPTM1L P4HA1 LRP1 | 1.40e-05 | 1201 | 104 | 14 | 35696571 |
| Pubmed | 1.44e-05 | 49 | 104 | 4 | 34368113 | ||
| Pubmed | RANBP2 MINK1 PSD3 ITGA6 ITPR3 PPP4C P4HA1 CD2BP2 STYXL1 TNS1 HSP90AA1 PHLPP2 HSP90AB1 | 1.54e-05 | 1049 | 104 | 13 | 27880917 | |
| Pubmed | RANBP2 RIPOR2 HIVEP2 LAMA4 STK32C PAK3 TNS1 HSP90AA1 HSP90AB1 | 1.60e-05 | 486 | 104 | 9 | 20936779 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.68e-05 | 372 | 104 | 8 | 22939624 | |
| Pubmed | 2.05e-05 | 18 | 104 | 3 | 34171383 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 28790178 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 26397136 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 34727930 | ||
| Pubmed | Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo. | 2.65e-05 | 3 | 104 | 2 | 20226818 | |
| Pubmed | Differential PI(4,5)P2 sensitivities of TRPC4, C5 homomeric and TRPC1/4, C1/5 heteromeric channels. | 2.65e-05 | 3 | 104 | 2 | 30755645 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 16877351 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10995457 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 20937816 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18550790 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19158073 | ||
| Pubmed | No association between COL3A1, COL6A1 or COL12A1 gene variants and range of motion. | 2.65e-05 | 3 | 104 | 2 | 23013106 | |
| Pubmed | Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. | 2.65e-05 | 3 | 104 | 2 | 22849407 | |
| Pubmed | Genetics of migraine in the age of genome-wide association studies. | 2.65e-05 | 3 | 104 | 2 | 22072275 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19996089 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24952482 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17611647 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 21555854 | ||
| Pubmed | Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures. | 2.65e-05 | 3 | 104 | 2 | 15358771 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19826001 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 33344146 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 7753822 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 34199280 | ||
| Pubmed | Molecular recognition via coupled folding and binding in a TPR domain. | 2.65e-05 | 3 | 104 | 2 | 15713458 | |
| Pubmed | Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. | 2.65e-05 | 3 | 104 | 2 | 17555712 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 2492519 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 1406681 | ||
| Pubmed | Mammalian CHORD-containing protein 1 is a novel heat shock protein 90-interacting protein. | 2.65e-05 | 3 | 104 | 2 | 15642353 | |
| Pubmed | Tensin1 positively regulates RhoA activity through its interaction with DLC1. | 2.65e-05 | 3 | 104 | 2 | 26427649 | |
| Interaction | SRMS interactions | 1.64e-06 | 40 | 101 | 5 | int:SRMS | |
| Interaction | LIMK2 interactions | 4.04e-06 | 84 | 101 | 6 | int:LIMK2 | |
| Interaction | SBK2 interactions | 4.21e-06 | 7 | 101 | 3 | int:SBK2 | |
| Interaction | STK32C interactions | 4.96e-06 | 87 | 101 | 6 | int:STK32C | |
| Interaction | CDKL5 interactions | 2.24e-05 | 113 | 101 | 6 | int:CDKL5 | |
| Cytoband | 3p22-p21.3 | 3.04e-05 | 4 | 104 | 2 | 3p22-p21.3 | |
| Cytoband | 17q21.2 | 5.54e-04 | 70 | 104 | 3 | 17q21.2 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 2.19e-06 | 24 | 71 | 4 | 485 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.74e-05 | 181 | 71 | 6 | 694 | |
| GeneFamily | Heat shock 90kDa proteins | 1.51e-04 | 5 | 71 | 2 | 586 | |
| GeneFamily | Transient receptor potential cation channels | 1.77e-04 | 28 | 71 | 3 | 249 | |
| GeneFamily | Collagens | 7.80e-04 | 46 | 71 | 3 | 490 | |
| GeneFamily | Low density lipoprotein receptors | 1.15e-03 | 13 | 71 | 2 | 634 | |
| GeneFamily | ATP binding cassette subfamily A | 1.34e-03 | 14 | 71 | 2 | 805 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 6.96e-06 | 177 | 104 | 7 | M39245 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HIVEP2 RSPH4A ABCA13 ADGRV1 CSMD3 LRP1B SLC18A1 TRPM8 HSP90AA1 | 2.23e-10 | 169 | 103 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 184 | 103 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 184 | 103 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-07 | 184 | 103 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 191 | 103 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 191 | 103 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 191 | 103 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.13e-07 | 191 | 103 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-07 | 192 | 103 | 7 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-07 | 192 | 103 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-07 | 195 | 103 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | 5'-GW_trimst-2|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-07 | 198 | 103 | 7 | 677816ea6d1706d99b7757d43b6b375276b25639 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.12e-07 | 199 | 103 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-07 | 200 | 103 | 7 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-07 | 200 | 103 | 7 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-06 | 150 | 103 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.91e-06 | 159 | 103 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | VE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 2.54e-06 | 167 | 103 | 6 | 1036ac1ef9440612500137af9d1929672b077e4d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-06 | 175 | 103 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 181 | 103 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 181 | 103 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.04e-06 | 181 | 103 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 184 | 103 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 5.17e-06 | 189 | 103 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-06 | 190 | 103 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-06 | 190 | 103 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.33e-06 | 190 | 103 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 192 | 103 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-06 | 192 | 103 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.66e-06 | 192 | 103 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.66e-06 | 192 | 103 | 6 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-06 | 193 | 103 | 6 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 193 | 103 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.83e-06 | 193 | 103 | 6 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.83e-06 | 193 | 103 | 6 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.01e-06 | 194 | 103 | 6 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-06 | 194 | 103 | 6 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 195 | 103 | 6 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 195 | 103 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.19e-06 | 195 | 103 | 6 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 195 | 103 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-06 | 195 | 103 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 6.37e-06 | 196 | 103 | 6 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.37e-06 | 196 | 103 | 6 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 196 | 103 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 197 | 103 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 197 | 103 | 6 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 197 | 103 | 6 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 6.56e-06 | 197 | 103 | 6 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 197 | 103 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-06 | 198 | 103 | 6 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 6.75e-06 | 198 | 103 | 6 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 6.95e-06 | 199 | 103 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 199 | 103 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | 3'-GW_trimst-1.5|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.95e-06 | 199 | 103 | 6 | 8e69d718ed5b05b08550973c33c92f0c6bfccc68 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 7.15e-06 | 200 | 103 | 6 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.08e-05 | 125 | 103 | 5 | c82b4bddc98b2a2d2ee00c1392df86f9735c0623 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 130 | 103 | 5 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 148 | 103 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.23e-05 | 157 | 103 | 5 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l32|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-05 | 79 | 103 | 4 | 11e92ae55dae24b6f73dd5a52e1c3c4e579ddf7b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 160 | 103 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 160 | 103 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.64e-05 | 161 | 103 | 5 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-05 | 164 | 103 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 168 | 103 | 5 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-05 | 168 | 103 | 5 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 4.85e-05 | 171 | 103 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 173 | 103 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 173 | 103 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-05 | 174 | 103 | 5 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.26e-05 | 174 | 103 | 5 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.41e-05 | 175 | 103 | 5 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 175 | 103 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 176 | 103 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 176 | 103 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.71e-05 | 177 | 103 | 5 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.71e-05 | 177 | 103 | 5 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 5.71e-05 | 177 | 103 | 5 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-05 | 179 | 103 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.02e-05 | 179 | 103 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.02e-05 | 179 | 103 | 5 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.02e-05 | 179 | 103 | 5 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 180 | 103 | 5 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 180 | 103 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 180 | 103 | 5 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.18e-05 | 180 | 103 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 180 | 103 | 5 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 181 | 103 | 5 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 181 | 103 | 5 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 181 | 103 | 5 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.51e-05 | 182 | 103 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.51e-05 | 182 | 103 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.51e-05 | 182 | 103 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.51e-05 | 182 | 103 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.51e-05 | 182 | 103 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.20e-07 | 200 | 103 | 9 | 6838_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.98e-06 | 195 | 103 | 8 | 3321_UP | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 3.09e-06 | 196 | 103 | 8 | 6396_DN | |
| Drug | NSC330499 | 3.11e-06 | 7 | 103 | 3 | CID000433447 | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.21e-06 | 197 | 103 | 8 | 5447_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.46e-06 | 199 | 103 | 8 | 5459_UP | |
| Drug | phenyldichloroarsine | 4.95e-06 | 8 | 103 | 3 | CID000012762 | |
| Drug | 5,8-quinolinedione | 7.41e-06 | 9 | 103 | 3 | CID000388306 | |
| Drug | Kdel Sequence | 9.06e-06 | 62 | 103 | 5 | CID000123910 | |
| Drug | Pu-3 | 1.44e-05 | 11 | 103 | 3 | CID000448965 | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.61e-05 | 177 | 103 | 7 | 4495_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.61e-05 | 177 | 103 | 7 | 3993_UP | |
| Drug | malotilate | 1.77e-05 | 71 | 103 | 5 | CID000004006 | |
| Drug | 3-amino-5-chlorobenzoic acid | 2.03e-05 | 2 | 103 | 2 | CID010986726 | |
| Drug | monocillin III | 2.03e-05 | 2 | 103 | 2 | CID006478910 | |
| Drug | pochonin A | 2.03e-05 | 2 | 103 | 2 | CID006478909 | |
| Drug | PU-H71 | 2.03e-05 | 2 | 103 | 2 | CID009549213 | |
| Drug | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | 2.03e-05 | 2 | 103 | 2 | DB02754 | |
| Drug | 1uyc | 2.03e-05 | 2 | 103 | 2 | CID000448969 | |
| Drug | PU-9 | 2.03e-05 | 2 | 103 | 2 | CID000448971 | |
| Drug | P u 0 | 2.03e-05 | 2 | 103 | 2 | CID000448974 | |
| Drug | 2qf6 | 2.03e-05 | 2 | 103 | 2 | CID013373715 | |
| Drug | Geldanamycin | 2.03e-05 | 2 | 103 | 2 | DB02424 | |
| Drug | CHEBI:42139 | 2.03e-05 | 2 | 103 | 2 | CID011562562 | |
| Drug | 2qfo | 2.03e-05 | 2 | 103 | 2 | CID000600769 | |
| Drug | 3eko | 2.03e-05 | 2 | 103 | 2 | CID011160307 | |
| Drug | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE | 2.03e-05 | 2 | 103 | 2 | DB07877 | |
| Drug | 1uyi | 2.03e-05 | 2 | 103 | 2 | CID005289232 | |
| Drug | 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL | 2.03e-05 | 2 | 103 | 2 | DB07594 | |
| Drug | NSC683666 | 2.03e-05 | 2 | 103 | 2 | CID005469153 | |
| Drug | H 64 | 2.03e-05 | 2 | 103 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 2.03e-05 | 2 | 103 | 2 | CID015942101 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.14e-05 | 185 | 103 | 7 | 6973_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.46e-05 | 189 | 103 | 7 | 4430_UP | |
| Drug | MMTS | 2.59e-05 | 38 | 103 | 4 | CID000099129 | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.72e-05 | 192 | 103 | 7 | 2561_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A | 2.81e-05 | 193 | 103 | 7 | 3989_UP | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.91e-05 | 194 | 103 | 7 | 4951_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.91e-05 | 194 | 103 | 7 | 3977_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; MCF7; HT_HG-U133A | 2.91e-05 | 194 | 103 | 7 | 2743_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.91e-05 | 194 | 103 | 7 | 2223_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 4746_UP | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 4234_DN | |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 3.00e-05 | 195 | 103 | 7 | 268_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 3.10e-05 | 196 | 103 | 7 | 5771_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; PC3; HT_HG-U133A | 3.10e-05 | 196 | 103 | 7 | 3700_UP | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.10e-05 | 196 | 103 | 7 | 5642_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 3004_DN | |
| Drug | celecoxib; Down 200; 10uM; PC3; HG-U133A | 3.21e-05 | 197 | 103 | 7 | 482_DN | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A | 3.21e-05 | 197 | 103 | 7 | 435_DN | |
| Drug | Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 3189_UP | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 4171_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 3723_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 2234_UP | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 5053_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 6178_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 4348_UP | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 3230_UP | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 6740_DN | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 2808_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 2266_UP | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; HL60; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 2995_UP | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 2841_DN | |
| Drug | Trimethadione [127-48-0]; Up 200; 28uM; PC3; HT_HG-U133A | 3.53e-05 | 200 | 103 | 7 | 4086_UP | |
| Drug | AC1L9PMA | 3.93e-05 | 15 | 103 | 3 | CID000451405 | |
| Drug | $l^{1}-borane | 4.67e-05 | 44 | 103 | 4 | CID006397184 | |
| Drug | thiolutin | 4.82e-05 | 16 | 103 | 3 | CID000006870 | |
| Drug | dexamethasone 21-mesylate | 4.82e-05 | 16 | 103 | 3 | CID000063041 | |
| Drug | 4-hydroxyproline | 5.87e-05 | 91 | 103 | 5 | CID000000825 | |
| Drug | pochonin D | 6.06e-05 | 3 | 103 | 2 | CID006478913 | |
| Drug | azaquinone | 6.06e-05 | 3 | 103 | 2 | CID000099132 | |
| Drug | d 1 v | 6.06e-05 | 3 | 103 | 2 | CID000683940 | |
| Drug | AC1MD0RC | 6.06e-05 | 3 | 103 | 2 | CID002829073 | |
| Drug | NSC326198 | 6.06e-05 | 3 | 103 | 2 | CID005359777 | |
| Drug | HM-9 | 6.06e-05 | 3 | 103 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 6.06e-05 | 3 | 103 | 2 | CID000133564 | |
| Drug | DCDD | 8.27e-05 | 19 | 103 | 3 | CID000036613 | |
| Drug | dimethyl pimelimidate | 9.69e-05 | 20 | 103 | 3 | CID000065403 | |
| Drug | NSC49633 | 9.75e-05 | 53 | 103 | 4 | CID000023340 | |
| Drug | beryllium fluoride | 1.06e-04 | 103 | 103 | 5 | CID000024589 | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 1.13e-04 | 167 | 103 | 6 | 6187_UP | |
| Drug | gold nanoparticles | 1.20e-04 | 243 | 103 | 7 | CID000023985 | |
| Drug | N-(5-methylisoxazol-3-yl)-2-(4-(thiophen-2-yl)-6-(trifluoromethyl)pyrimidin-2-ylthio)acetamide | 1.21e-04 | 4 | 103 | 2 | ctd:C576667 | |
| Drug | uranyl chloride | 1.21e-04 | 4 | 103 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 1.21e-04 | 4 | 103 | 2 | CID000069988 | |
| Drug | 11p110 | 1.21e-04 | 4 | 103 | 2 | CID002382787 | |
| Drug | ATFP | 1.21e-04 | 4 | 103 | 2 | CID000193783 | |
| Drug | tamoxifen aziridine | 1.30e-04 | 22 | 103 | 3 | CID003033894 | |
| Drug | CCT018159 | 1.30e-04 | 22 | 103 | 3 | CID005327091 | |
| Drug | hydroxylysine | 1.38e-04 | 109 | 103 | 5 | CID000001029 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.46e-04 | 175 | 103 | 6 | 7073_UP | |
| Drug | S2A | 1.49e-04 | 23 | 103 | 3 | CID016058643 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.55e-04 | 177 | 103 | 6 | 6943_UP | |
| Drug | alpha-ketoglutarate | 1.58e-04 | 254 | 103 | 7 | CID000000051 | |
| Drug | LG 5 | 1.59e-04 | 60 | 103 | 4 | CID011840957 | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.81e-04 | 182 | 103 | 6 | 2230_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.81e-04 | 182 | 103 | 6 | 7503_UP | |
| Drug | 2,7,8-trihydroxyanthraquinone | 2.01e-04 | 5 | 103 | 2 | CID000065739 | |
| Drug | 1uyd | 2.01e-04 | 5 | 103 | 2 | CID000448970 | |
| Drug | HCV-796 | 2.01e-04 | 5 | 103 | 2 | CID011561383 | |
| Disease | Colorectal Carcinoma | COL3A1 COL7A1 ABCA4 ABCA13 ABCB5 STK32C CSMD3 ADCY8 ABCG1 DLC1 LRP1 ALDH2 | 5.73e-06 | 702 | 102 | 12 | C0009402 |
| Disease | Granuloma, Plasma Cell | 1.18e-05 | 2 | 102 | 2 | C0018199 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 1.77e-05 | 15 | 102 | 3 | EFO_0004847, MONDO_0004976 | |
| Disease | cortical thickness | P4HA2 RIPOR2 COL12A1 ABCA4 CUL9 EXT1 ADGRV1 JMJD1C SLC45A4 ABCG1 DLC1 LRP1 TNS1 KDM4B | 2.94e-05 | 1113 | 102 | 14 | EFO_0004840 |
| Disease | Trichilemmal cyst | 3.54e-05 | 3 | 102 | 2 | HP_0025246 | |
| Disease | Colorectal Neoplasms | 5.14e-05 | 277 | 102 | 7 | C0009404 | |
| Disease | diffuse plaque measurement | SDK2 ABCA13 PSD3 CSMD3 LRP1B ARFGEF3 DLC1 BTNL2 RBFOX1 TNS1 HSP90AA4P | 6.39e-05 | 758 | 102 | 11 | EFO_0010699 |
| Disease | Ki-1+ Anaplastic Large Cell Lymphoma | 7.07e-05 | 4 | 102 | 2 | C0206180 | |
| Disease | migraine disorder, glucose measurement | 1.68e-04 | 31 | 102 | 3 | EFO_0004468, MONDO_0005277 | |
| Disease | Inflammatory Myofibroblastic Tumor | 1.76e-04 | 6 | 102 | 2 | C0334121 | |
| Disease | Common Migraine | 2.46e-04 | 7 | 102 | 2 | C0338480 | |
| Disease | heparin cofactor 2 measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0008150 | |
| Disease | beta-citrylglutamate measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0800060 | |
| Disease | epilepsy (implicated_via_orthology) | 2.62e-04 | 163 | 102 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | childhood aggressive behaviour measurement | 2.62e-04 | 89 | 102 | 4 | EFO_0007663 | |
| Disease | urate measurement | P4HA2 COL7A1 RIPOR2 PSD3 EXT1 ADGRV1 JMJD1C RBFOX1 LRP1 ALDH2 KDM4B | 2.72e-04 | 895 | 102 | 11 | EFO_0004531 |
| Disease | asthma | 2.79e-04 | 751 | 102 | 10 | MONDO_0004979 | |
| Disease | PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME | 3.27e-04 | 8 | 102 | 2 | C0796250 | |
| Disease | cancer (implicated_via_orthology) | 3.45e-04 | 268 | 102 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Acute Confusional Migraine | 4.19e-04 | 9 | 102 | 2 | C0521664 | |
| Disease | Status Migrainosus | 4.19e-04 | 9 | 102 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 4.19e-04 | 9 | 102 | 2 | C0270858 | |
| Disease | Sick Headaches | 4.19e-04 | 9 | 102 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 4.19e-04 | 9 | 102 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 4.19e-04 | 9 | 102 | 2 | C0018984 | |
| Disease | response to corticosteroid, age at assessment | 5.23e-04 | 10 | 102 | 2 | EFO_0008007, GO_0031960 | |
| Disease | alopecia areata (is_marker_for) | 5.23e-04 | 10 | 102 | 2 | DOID:986 (is_marker_for) | |
| Disease | apolipoprotein A 1 measurement | COL7A1 TMPRSS11E PSD3 JMJD1C DLC1 SLC18A1 NANS BTNL2 FER LRP1 | 7.17e-04 | 848 | 102 | 10 | EFO_0004614 |
| Disease | pulmonary function measurement, forced expiratory volume, smoking behaviour measurement | 7.64e-04 | 12 | 102 | 2 | EFO_0003892, EFO_0004314, EFO_0005671 | |
| Disease | nicotine dependence (implicated_via_orthology) | 7.64e-04 | 12 | 102 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | coronary artery disease | P4HA2 HIVEP2 PSD3 DLC1 SLC18A1 RBFOX1 FER LRP1 ALDH2 TNS1 ALK KDM4B | 8.61e-04 | 1194 | 102 | 12 | EFO_0001645 |
| Disease | Migraine Disorders | 9.00e-04 | 13 | 102 | 2 | C0149931 | |
| Disease | melanoma | 9.75e-04 | 126 | 102 | 4 | EFO_0000756 | |
| Disease | reticulocyte count | KLHL10 UBAP2 LAMA4 TENT5C JMJD1C ADCY8 NARS2 SLC45A4 KLHL11 TNS1 HSP90AB1 | 9.84e-04 | 1045 | 102 | 11 | EFO_0007986 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.00e-03 | 127 | 102 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | 1-methylurate measurement | 1.05e-03 | 14 | 102 | 2 | EFO_0021173 | |
| Disease | allergic rhinitis | 1.19e-03 | 133 | 102 | 4 | EFO_0005854 | |
| Disease | Anilide use measurement | 1.21e-03 | 15 | 102 | 2 | EFO_0009938 | |
| Disease | isocitrate measurement | 1.38e-03 | 16 | 102 | 2 | EFO_0010505 | |
| Disease | migraine without aura, susceptibility to, 4 | 1.38e-03 | 16 | 102 | 2 | MONDO_0011847 | |
| Disease | melanoma | 1.73e-03 | 248 | 102 | 5 | C0025202 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.94e-03 | 152 | 102 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | facial attractiveness measurement | 1.95e-03 | 19 | 102 | 2 | EFO_0009892 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.95e-03 | 19 | 102 | 2 | DOID:4928 (is_marker_for) | |
| Disease | intraocular pressure measurement | 1.97e-03 | 509 | 102 | 7 | EFO_0004695 | |
| Disease | glucose measurement | 2.09e-03 | 380 | 102 | 6 | EFO_0004468 | |
| Disease | nucleotide measurement | 2.09e-03 | 73 | 102 | 3 | EFO_0010513 | |
| Disease | lung cancer (is_implicated_in) | 2.18e-03 | 74 | 102 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | juvenile idiopathic arthritis | 2.18e-03 | 74 | 102 | 3 | EFO_0002609 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.26e-03 | 75 | 102 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.29e-03 | 670 | 102 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Antimigraine preparation use measurement | 2.38e-03 | 21 | 102 | 2 | EFO_0009939 | |
| Disease | haptoglobin measurement | 2.38e-03 | 21 | 102 | 2 | EFO_0004640 | |
| Disease | sex interaction measurement, bilirubin measurement | 2.61e-03 | 22 | 102 | 2 | EFO_0004570, EFO_0008343 | |
| Disease | Nonsyndromic Deafness | 2.81e-03 | 81 | 102 | 3 | C3711374 | |
| Disease | sphingomyelin measurement | 2.84e-03 | 278 | 102 | 5 | EFO_0010118 | |
| Disease | liver fibrosis measurement | 3.33e-03 | 86 | 102 | 3 | EFO_0010576 | |
| Disease | epiandrosterone sulfate measurement | 3.37e-03 | 25 | 102 | 2 | EFO_0021120 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSYDAVGVMFASIPG | 976 | P40145 | |
| VGVMFASIPGFADFY | 981 | P40145 | |
| AMDGFVSAEPDGATY | 3576 | Q7Z407 | |
| GQQYTFFSMDEPGSE | 1411 | P78363 | |
| PADFVMEVASGEYGD | 321 | P45844 | |
| MVDFPGYNLSGAVAS | 1 | Q9UIR0 | |
| PEGMFIVFTAIAYGA | 951 | Q2M3G0 | |
| GQEFYETSGTVNFMD | 1166 | Q8WXG9 | |
| GIDSYVSPFEMNFLG | 4641 | Q86UQ4 | |
| ETVTTGNVMGPYFAF | 116 | Q96M93 | |
| GNVMGPYFAFCAVVD | 121 | Q96M93 | |
| SFQMYGEDFVPDIVT | 261 | Q8TBG4 | |
| DSVYTGGTEVMVPSF | 2776 | P49792 | |
| AYETMAGAGVPFSAN | 561 | O94776 | |
| FFYPYMEGASTGVLD | 2221 | Q14573 | |
| PSFSTFMDGYTGEFD | 51 | P22736 | |
| IVYGDQDPMGQTSFE | 156 | Q96IU4 | |
| GFSMEVGQYIFVNCP | 316 | Q9Y5S8 | |
| MSQYITVGSNPFTGF | 301 | Q9H2M9 | |
| AVTGEFTPDLYGSQM | 86 | O75914 | |
| ADISMIGQFGVGFYS | 121 | P08238 | |
| MAAPPGEYFSVGSQV | 1 | Q3MHD2 | |
| GSNVDMFSVAVFGAY | 2081 | Q9NZR2 | |
| GYENFGNSFMVPVDA | 416 | Q9UDY8 | |
| DPAMGKVFFTDYGQI | 331 | Q07954 | |
| MAGPESDAQYQFTGI | 1 | Q96IX5 | |
| STDAGIAFAPVYSMG | 2081 | Q15652 | |
| GEYIASGQVTFMGFK | 76 | Q8N1V2 | |
| QSFGAVTPGYDFMAR | 76 | P41247 | |
| TQEAGEFMITFPYGY | 261 | O75164 | |
| ITQEAGEFMITFPYG | 261 | O94953 | |
| QEAGEFMVTFPYGYH | 266 | Q6B0I6 | |
| FFDMNIFEDGPYEVG | 226 | P23229 | |
| VYVGGNFVESMAPAS | 356 | P31249 | |
| GSVPEGTEMFEVYGT | 31 | Q9ULW8 | |
| IYDNVFDGSGTDMEP | 1291 | P09884 | |
| TFDAGSPGFQLRYMV | 711 | O75161 | |
| TGPYVIGFMDSFVNV | 146 | Q8N146 | |
| NYMSDVEAGGATVFP | 456 | O15460 | |
| GTPGQAFYEMASFSE | 511 | P51178 | |
| YMSDVSAGGATVFPE | 456 | P13674 | |
| PMFFYVTQGQEEIAS | 756 | Q92900 | |
| GDAELYGPFTSAQMQ | 291 | O95400 | |
| VTVLGNFIYAMGGFD | 381 | Q6JEL2 | |
| ESYVYVAGSMEPGFA | 406 | Q9NVR0 | |
| PDYTEDVGFDIGQAM | 201 | Q16394 | |
| TTYKVNVFGMFDGGE | 1151 | Q99715 | |
| MVGSYGPSAQEYEFV | 166 | Q99819 | |
| DNMYRFEGTGFSNIP | 511 | P16591 | |
| DYSMGKGQAPVFDVF | 1321 | Q5TH69 | |
| GLYTTVDFGPADNMT | 231 | Q6UWU2 | |
| DSSYMPARVVVFGGD | 1226 | Q8IWT3 | |
| SMDGGFQFSYGNPEL | 1331 | P02461 | |
| GMDSVQTFFAVDDGP | 1206 | Q02388 | |
| ADISMIGQFGVGFYS | 126 | P07900 | |
| ADISMIGQFSVGFYS | 66 | Q58FG1 | |
| YMVSVAAFNAAGDGP | 1696 | Q58EX2 | |
| ADISMIGQFGVSFYS | 126 | Q14568 | |
| FEGPMETGTYFSTEG | 1641 | Q16363 | |
| FTMFVDLGIYQPGGS | 951 | Q8N4C8 | |
| PEFIVQTGSYMFVDE | 41 | A6ZKI3 | |
| MESAFYFEQAGVGLG | 316 | Q5TD94 | |
| TYGVGAMNAFAPLTD | 351 | Q9NWB1 | |
| PSVAMEGVRAGYFFS | 176 | Q17R31 | |
| GFSSGYFSLMPVVTE | 416 | Q7RTX9 | |
| EVMSGAFTQVFTFGP | 226 | Q96I59 | |
| LMAVGETGNFAAYGF | 96 | Q9H841 | |
| VGDNPMSDVYGANLF | 311 | Q9BXW7 | |
| MYGDIFNATGGPEAA | 1 | A0A1B0GUA5 | |
| YAEEVGIFFTASGMD | 101 | Q9NR45 | |
| EVAVAGFGYDMSTPN | 316 | Q11203 | |
| GRYFAGTMAEETAPA | 111 | Q15493 | |
| RVGMYLEGFDPFNQS | 771 | Q96QB1 | |
| YPFDVEDMTASSGAG | 316 | Q9Y4F9 | |
| FHPTVIGESMYGDFE | 206 | Q5VWP2 | |
| YMAPEIFHSFVNGGT | 256 | Q86UX6 | |
| AFGEVYEGQVSGMPN | 1126 | Q9UM73 | |
| YFIQPTVFGDVQDGM | 396 | P05091 | |
| MGFNSGYAVNPARDF | 206 | Q92482 | |
| GLMPEFQFGTYSESE | 376 | Q96KA5 | |
| YIAPERFVDGGMFAT | 196 | Q99570 | |
| AVFYTDFMGQVIFEG | 526 | Q5BKX6 | |
| ASYEFQPGDVMFVTG | 301 | Q9UL52 | |
| FSTQGMGTFNPADYS | 186 | Q5T6F2 | |
| MATSQYFDFAQGGGP | 1 | Q9UPR6 | |
| SGPEYASFFAVMGAS | 6 | P27449 | |
| EMEPISIYFSQGGQA | 66 | Q86XK7 | |
| FSAQGMGTFNPADYA | 191 | Q14157 | |
| EPGTNFVYAQFDGIM | 166 | P20142 | |
| DSFAEGVGAVYGMFD | 806 | Q6ZVD8 | |
| VNVSMDTGPFFAGDA | 191 | Q9Y6J8 | |
| PNVGGYFVDKFVATM | 281 | Q92791 | |
| EFVFSYGPEKIQGME | 301 | Q9HBL0 | |
| GNLGFYFDVMEITPE | 371 | O75191 | |
| MSYGSITFGDVAIDF | 1 | Q96SK3 | |
| EPYVTEMAQGTFGGV | 326 | Q5H9I0 | |
| TVGQAVAYMAPGSFA | 116 | Q8N4Q0 | |
| FAGPYFVSEDNMAFG | 86 | Q9H0R3 | |
| FTEFVGATMFGTYNV | 596 | Q9UL62 | |
| MFGQVPSDVDGTTYD | 911 | Q7Z2W7 | |
| FDERMTGSDDVFYPG | 566 | P31629 | |
| FRVGGDVPETNYLFM | 66 | P60510 | |
| VTNEFPEYGTMEEGG | 56 | Q9NYI0 | |
| EFTEFVGATMFGTYN | 591 | Q9UBN4 | |
| FGSVMYEFVGKSAPF | 246 | P54219 | |
| YNAFSAQGMPEGDLV | 151 | Q9Y3Q0 |